
Anne L. Holleran
Examiner (ID: 1384, Phone: (571)272-0833 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1643, 1642 |
| Total Applications | 775 |
| Issued Applications | 297 |
| Pending Applications | 125 |
| Abandoned Applications | 356 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6925364
[patent_doc_number] => 20050238619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Method for the delivery of sustained release agents'
[patent_app_type] => utility
[patent_app_number] => 11/082851
[patent_app_country] => US
[patent_app_date] => 2005-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3249
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20050238619.pdf
[firstpage_image] =>[orig_patent_app_number] => 11082851
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/082851 | Method for the delivery of sustained release agents | Mar 17, 2005 | Abandoned |
Array
(
[id] => 7514926
[patent_doc_number] => 08038996
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-18
[patent_title] => 'Composition and method for cancer treatment'
[patent_app_type] => utility
[patent_app_number] => 11/075891
[patent_app_country] => US
[patent_app_date] => 2005-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 11071
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/038/08038996.pdf
[firstpage_image] =>[orig_patent_app_number] => 11075891
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/075891 | Composition and method for cancer treatment | Mar 9, 2005 | Issued |
Array
(
[id] => 5085335
[patent_doc_number] => 20070275386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-29
[patent_title] => 'Polymorphisms in the Epidermal Growth Factor Receptor Gene Promoter'
[patent_app_type] => utility
[patent_app_number] => 10/591228
[patent_app_country] => US
[patent_app_date] => 2005-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17047
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20070275386.pdf
[firstpage_image] =>[orig_patent_app_number] => 10591228
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/591228 | Polymorphisms in the Epidermal Growth Factor Receptor Gene Promoter | Feb 28, 2005 | Abandoned |
Array
(
[id] => 6966022
[patent_doc_number] => 20050232919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Monoclonal antibodies that specifically block biological activity of a tumor antigen'
[patent_app_type] => utility
[patent_app_number] => 11/056776
[patent_app_country] => US
[patent_app_date] => 2005-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18986
[patent_no_of_claims] => 91
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20050232919.pdf
[firstpage_image] =>[orig_patent_app_number] => 11056776
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/056776 | Monoclonal antibodies that specifically block biological activity of a tumor antigen | Feb 10, 2005 | Abandoned |
Array
(
[id] => 4443862
[patent_doc_number] => 07862817
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-04
[patent_title] => 'Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/044749
[patent_app_country] => US
[patent_app_date] => 2005-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 21
[patent_no_of_words] => 36366
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/862/07862817.pdf
[firstpage_image] =>[orig_patent_app_number] => 11044749
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/044749 | Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies | Jan 26, 2005 | Issued |
Array
(
[id] => 7136625
[patent_doc_number] => 20050181401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-18
[patent_title] => 'Reagents and methods useful for detecting diseases of the prostate'
[patent_app_type] => utility
[patent_app_number] => 11/043675
[patent_app_country] => US
[patent_app_date] => 2005-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 37470
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20050181401.pdf
[firstpage_image] =>[orig_patent_app_number] => 11043675
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/043675 | Reagents and methods useful for detecting diseases of the prostate | Jan 25, 2005 | Abandoned |
Array
(
[id] => 8294208
[patent_doc_number] => 08221993
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-17
[patent_title] => 'Methods of detecting methyl transferase activity and methods of screening for methyl transferase activity modulators'
[patent_app_type] => utility
[patent_app_number] => 10/586987
[patent_app_country] => US
[patent_app_date] => 2005-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 8
[patent_no_of_words] => 14575
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10586987
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/586987 | Methods of detecting methyl transferase activity and methods of screening for methyl transferase activity modulators | Jan 20, 2005 | Issued |
Array
(
[id] => 6996689
[patent_doc_number] => 20050136467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'ErbB4 receptor-specific neuregulin related ligands and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 11/035787
[patent_app_country] => US
[patent_app_date] => 2005-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 33251
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20050136467.pdf
[firstpage_image] =>[orig_patent_app_number] => 11035787
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/035787 | ErbB4 receptor-specific neuregulin related ligands and uses therefor | Jan 13, 2005 | Abandoned |
Array
(
[id] => 5085837
[patent_doc_number] => 20070275888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-29
[patent_title] => 'Preventive/Remedy for Cancer'
[patent_app_type] => utility
[patent_app_number] => 10/584183
[patent_app_country] => US
[patent_app_date] => 2004-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44369
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20070275888.pdf
[firstpage_image] =>[orig_patent_app_number] => 10584183
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/584183 | Preventive/Remedy for Cancer | Dec 23, 2004 | Abandoned |
Array
(
[id] => 6939766
[patent_doc_number] => 20050113329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Diagnosis and treatment of malignant neoplasms'
[patent_app_type] => utility
[patent_app_number] => 11/020965
[patent_app_country] => US
[patent_app_date] => 2004-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18614
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20050113329.pdf
[firstpage_image] =>[orig_patent_app_number] => 11020965
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/020965 | Diagnosis and treatment of malignant neoplasms | Dec 22, 2004 | Abandoned |
Array
(
[id] => 6938557
[patent_doc_number] => 20050112120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Treatment of refractory human tumors with epidermal growth factor receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/018950
[patent_app_country] => US
[patent_app_date] => 2004-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6423
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112120.pdf
[firstpage_image] =>[orig_patent_app_number] => 11018950
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/018950 | Treatment of refractory human tumors with epidermal growth factor receptor antagonists | Dec 19, 2004 | Abandoned |
Array
(
[id] => 7168267
[patent_doc_number] => 20050201993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase'
[patent_app_type] => utility
[patent_app_number] => 11/013685
[patent_app_country] => US
[patent_app_date] => 2004-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 22262
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20050201993.pdf
[firstpage_image] =>[orig_patent_app_number] => 11013685
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/013685 | Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase | Dec 15, 2004 | Abandoned |
Array
(
[id] => 5198715
[patent_doc_number] => 20070298033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-27
[patent_title] => 'Human Anti-Idiotypic Antibody Fragments that Mimic Her-2/Neu'
[patent_app_type] => utility
[patent_app_number] => 10/583034
[patent_app_country] => US
[patent_app_date] => 2004-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11476
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20070298033.pdf
[firstpage_image] =>[orig_patent_app_number] => 10583034
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/583034 | Human anti-idiotypic antibody fragments that mimic HER-2/neu | Dec 13, 2004 | Issued |
Array
(
[id] => 5409565
[patent_doc_number] => 20090123463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'Methods and compositions for inducing apoptosis'
[patent_app_type] => utility
[patent_app_number] => 10/579529
[patent_app_country] => US
[patent_app_date] => 2004-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 31413
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20090123463.pdf
[firstpage_image] =>[orig_patent_app_number] => 10579529
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/579529 | Methods and compositions for inducing apoptosis | Nov 16, 2004 | Issued |
Array
(
[id] => 6906223
[patent_doc_number] => 20050101618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Selective erbB2 inhibitor/anti-erbB antibody combinations in the treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 10/982996
[patent_app_country] => US
[patent_app_date] => 2004-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 29566
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20050101618.pdf
[firstpage_image] =>[orig_patent_app_number] => 10982996
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/982996 | Selective erbB2 inhibitor/anti-erbB antibody combinations in the treatment of cancer | Nov 3, 2004 | Abandoned |
Array
(
[id] => 7097257
[patent_doc_number] => 20050129715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Methods and compositions for immunotherapy of cancer'
[patent_app_type] => utility
[patent_app_number] => 10/949667
[patent_app_country] => US
[patent_app_date] => 2004-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 15183
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20050129715.pdf
[firstpage_image] =>[orig_patent_app_number] => 10949667
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/949667 | Methods and compositions for immunotherapy of cancer | Sep 23, 2004 | Issued |
Array
(
[id] => 7234022
[patent_doc_number] => 20050079562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-14
[patent_title] => 'Methods and compositions for diagnosis and monitoring of prostate cancer progression by detection of serum caveolin'
[patent_app_type] => utility
[patent_app_number] => 10/941747
[patent_app_country] => US
[patent_app_date] => 2004-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7266
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20050079562.pdf
[firstpage_image] =>[orig_patent_app_number] => 10941747
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/941747 | Methods and compositions for diagnosis and monitoring of prostate cancer progression by detection of serum caveolin | Sep 14, 2004 | Issued |
Array
(
[id] => 4572205
[patent_doc_number] => 07858760
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-28
[patent_title] => 'Antibodies to protein expressed in prostate cancer'
[patent_app_type] => utility
[patent_app_number] => 10/936138
[patent_app_country] => US
[patent_app_date] => 2004-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 26
[patent_no_of_words] => 28008
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/858/07858760.pdf
[firstpage_image] =>[orig_patent_app_number] => 10936138
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/936138 | Antibodies to protein expressed in prostate cancer | Sep 6, 2004 | Issued |
Array
(
[id] => 5732763
[patent_doc_number] => 20060257880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Gastric and prostate cancer associated antigens'
[patent_app_type] => utility
[patent_app_number] => 10/569572
[patent_app_country] => US
[patent_app_date] => 2004-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10860
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20060257880.pdf
[firstpage_image] =>[orig_patent_app_number] => 10569572
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/569572 | Gastric and prostate cancer associated antigens | Aug 26, 2004 | Abandoned |
Array
(
[id] => 5902484
[patent_doc_number] => 20060045883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-02
[patent_title] => 'Anti-cancer vaccines'
[patent_app_type] => utility
[patent_app_number] => 10/926852
[patent_app_country] => US
[patent_app_date] => 2004-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 49
[patent_no_of_words] => 66127
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20060045883.pdf
[firstpage_image] =>[orig_patent_app_number] => 10926852
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/926852 | Anti-cancer vaccines | Aug 25, 2004 | Abandoned |